[GeneFirst-Emerging] February 2026 Revenue: NT$36 Million (YoY +12.0%)
GeneFirst-Emerging announced its revenue for February 2026 reached NT$36 million, a 12.0% increase year-over-year. The revenue figures for the biotechnology company, which specializes in precision medicine, demonstrate stable growth in its genetic testing services business.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Stock Code: 6645
Company Name: GeneFirst-Emerging
Industry: Biotechnology and Medical Care
Data Month: 2026-02
Monthly Revenue: NT$35,863 thousand (NT$36 million)
Year-over-Year Change: +12.0%
Company Name: GeneFirst-Emerging
Industry: Biotechnology and Medical Care
Data Month: 2026-02
Monthly Revenue: NT$35,863 thousand (NT$36 million)
Year-over-Year Change: +12.0%